Detalhe da pesquisa
1.
SARS-CoV-2 receptor binding domain fusion protein efficiently neutralizes virus infection.
PLoS Pathog
; 17(12): e1010175, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34929007
2.
Maternal and Neonatal Severe Acute Respiratory Syndrome Coronavirus 2 Omicron Variant Neutralization After Antenatal Messenger RNA Vaccination.
Clin Infect Dis
; 75(11): 2023-2026, 2022 11 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-35607735
3.
Human Nasal and Lung Tissues Infected Ex Vivo with SARS-CoV-2 Provide Insights into Differential Tissue-Specific and Virus-Specific Innate Immune Responses in the Upper and Lower Respiratory Tract.
J Virol
; 95(14): e0013021, 2021 06 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-33893170
4.
Human Nasal Turbinate Tissues in Organ Culture as a Model for Human Cytomegalovirus Infection at the Mucosal Entry Site.
J Virol
; 94(19)2020 09 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-32727881
5.
Decidual-tissue-resident memory T cells protect against nonprimary human cytomegalovirus infection at the maternal-fetal interface.
Cell Rep
; 43(2): 113698, 2024 Feb 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-38265934
6.
Genome-wide loss-of-function screen using human pluripotent stem cells to study virus-host interactions for SARS-CoV-2.
Stem Cell Reports
; 18(9): 1766-1774, 2023 09 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37703821
7.
Anti-human ACE2 antibody neutralizes and inhibits virus production of SARS-CoV-2 variants of concern.
iScience
; 25(9): 104935, 2022 Sep 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-35992307
8.
SARS-CoV-2 Omicron Induces Enhanced Mucosal Interferon Response Compared to other Variants of Concern, Associated with Restricted Replication in Human Lung Tissues.
Viruses
; 14(7)2022 07 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-35891570
9.
Amniotic fluid biomarkers predict the severity of congenital cytomegalovirus infection.
J Clin Invest
; 132(11)2022 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35439172
10.
B cell-derived cfDNA after primary BNT162b2 mRNA vaccination anticipates memory B cells and SARS-CoV-2 neutralizing antibodies.
Med
; 3(7): 468-480.e5, 2022 07 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35716665